In Patients with a Chronic Type B Dissection, Does Endovascular Treatment Reduce Long Term Complications?

P (patients)
I (intervention)
C (comparator group)
O (outcomes measured)
Patients with Chronic Type B dissection
Endovascular treatment
Medical management (for uncomplicated type B dissection)
Open surgical repair (complicated type B dissection)
30 day mortality, early CVA and spinal cord ischemia (SCI), long-term survival, aortic event-free survival and rate of aortic re-interventions.
Table 2.2
Results for TEVAR in chronic complicated Type B aortic dissection
Author, year (ref.#)
n
30 day mortality N (%)
Early CVA N (%)
Early SCI N (%)
Mean f/up (m)
Survival (%)
Aortic event freedom rate
 
Aorta related death, reintervention, expansion free (%)
Aorta related death free (%)
Prospective nonrandomized trials
Virtue registry (2011, 2014) [10, 11]
50
0
0
1 (3.8)
36
1 year: 96
3 years: 74
1 year: 88
3 years: 68
1 year: 91.3
3 years: 74
Case series
Alves (2009) [13]
61
2 (3.3)
0
0
35.9
3 years: 94
3 years: 78
n/a
Parsa (2011) [16]
51
0
0
0
27
5 years: 77.7
5 years:77.3
5 years: 98
Kang (2011) [17]
76
4 (5)
1 (1.3)
0
34
1 year: 86
3 years: 80
1 year: 72
3 years: 59
1 year: 89
3 years: 86
Andacheh (2012) [18]
73
10 (14)
1 (1.3)
1 (1.3)
18
1 year: 81
1 year: 85
1 year: 86
Mani (2012) [19]
58
3 (5.2)
0
1 (1.7)
n/a
1 year: 89
3 years: 64
1 year: 85
3 years: 71
 
Cumulative
369
5.6 %
0.4 %
1.1 %
     
SCI spinal cord ischemia, CVA cerebral vascular accident, f/up follow up
Table 2.3
Results for medical treatment in chronic uncomplicated Type B aortic dissection
Author, year (ref.#)
n
30 days mortality N (%)
Early CVA N (%)
Early SCI N (%)
Mean f/up (m)
Survival (%)
Aortic event freedom rate
             
Aorta related death, reintervention, expansion free (%)
Aorta related death free (%)
Prospective randomized controlled trials
Nienaber INSTEAD (2009, 2013) [8, 9]
68
0
0
0
69
1 year: 82.5
15 years: 80.7 years: 97
1 year: 82.5
5 years: 53.9
1 year: 97
5 years: 80.7
Prospective nonrandomized trials
Jia (2013) [12]
68
0
0
0
69
1 year: 97
5 years: 80.7
1 year: 82.5
5 years: 53.9
1 year: 97
5 years: 80.7
Cumulative
163
0
0
0
       
Table 2.4
Results for TEVAR in chronic uncomplicated Type B aortic dissection
Author, year (ref.#)
n
30 days mortality N (%)
Early CVA N (%)
Early SCI N (%)
Mean f/up (m)
Survival (%)
Aortic event freedom rate
             
Aorta related death, reintervention, expansion free (%)
Aorta related death free (%)
Prospective randomized controlled trials
Nienaber INSTEAD (2009, 2013) [8, 9]
72
2 (2.8)
1 (1.4)
2 (2.9)
69
1 year: 91.3
5 years: 91.3
1 year: 83.3
5 years: 73
1 year: 94.2
5 years: 93.1
Prospective nonrandomized trials
Zipfel Restore registry (2011) [20]
51
3 (5)
0
2 (3.9)
10
N/a
n/a
n/a
Jia (2013) [12]
208
0
0
2 (0.9)
28.5
2 years: 87.5
4 years: 82.7
2 years: 87.8
4 years: 78.8
2 years: 91.6
4 years: 88.1
Case series
Kim (2009) [14]
72
0
0
0
64.4
5 years: 92
5 years: 83.9
5 years: 98.3
Xu (2009) [15]
84
1 (1.2)
0
0
33.2
3 years: 91.7
5 years: 84.4
7 years: 75.2
Kim (2009) [14]
72
0

Only gold members can continue reading. Log In or Register to continue

Stay updated, free articles. Join our Telegram channel

Oct 11, 2017 | Posted by in CARDIOLOGY | Comments Off on In Patients with a Chronic Type B Dissection, Does Endovascular Treatment Reduce Long Term Complications?

Full access? Get Clinical Tree

Get Clinical Tree app for offline access